<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="FTO obesity variant mechanism" Author="Alexander Pico" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Mechanism underlying the association of FTO locus variants and obesity. The wild type T allele at rs1421085 in the FTO locus comprises a protein-DNA binding motif for ARID5B that represses the transcription of IRX3 and IRX5, which in turn de-represses a set of thermogenic genes, leading to mitochondrial thermogenesis and a browning adipocyte program. The C risk allele, on the other hand, disrupts the binding motif for ARID5B and activates a mesenchymal superenhancer and its targets, IRX3 and IRX5, which represses thermogenesis and leads to a shift to lipid storage, white adipocytes and, thus, increased risk of obesity. 


In addition to the primary literature references associated with the pathway, also refer to this blog article providing additional perspective and drug discovery potential by Roger Plenge, "Article of the week: ARID5B-FTO-IRX3/IRX5 regulatory axis for drug discovery in obesity (NEJM)." August 21, 2015. http://www.plengegen.com/blog/arid5b-fto-irx3irx5-regulatory-axis-drug-discovery-obesity-nejm/</Comment>
  <BiopaxRef>fab</BiopaxRef>
  <BiopaxRef>af6</BiopaxRef>
  <Graphics BoardWidth="437.01206706867896" BoardHeight="492.7993159595626"/>
  <DataNode TextLabel="ARID5B" GraphId="c6fe8" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="IRX3" GraphId="e1668" Type="GeneProduct" GroupRef="c549d">
        </DataNode>
  <DataNode TextLabel="IRX5" GraphId="d7732" Type="GeneProduct" GroupRef="c549d">
        </DataNode>
  <DataNode TextLabel="UCP1" GraphId="f7d14" Type="GeneProduct" GroupRef="a9c7d">
        </DataNode>
  <DataNode TextLabel="PRDM16" GraphId="b70cf" Type="GeneProduct" GroupRef="a9c7d">
        </DataNode>
  <DataNode TextLabel="PPARGC1A" GraphId="d8875" Type="GeneProduct" GroupRef="a9c7d">
        </DataNode>
  <DataNode TextLabel="TBX1" GraphId="fb31e" Type="GeneProduct" GroupRef="a9c7d">
        </DataNode>
  <DataNode TextLabel="FTO" GraphId="bd803" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Fatty Acid Oxidation" GraphId="bdea0" Type="Pathway">
    <Graphics ShapeType="None" Color="14961e"/>
    </DataNode>
  <DataNode TextLabel="FTO" GraphId="da83e" Type="GeneProduct">
        </DataNode>
  <State GraphRef="bd803" TextLabel="C risk allele" GraphId="b2ba5">
    <Comment>C risk allele (rs1421085)</Comment>
    <Graphics ShapeType="Oval"/>
    </State>
  <State GraphRef="da83e" TextLabel="T risk allele" GraphId="ccfe6">
    <Graphics ShapeType="Oval"/>
    </State><Interaction GraphId="id3088f9b5">
    <Graphics>
      <Point GraphRef="c6fe8"/>
      <Point GraphRef="da83e" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id6296afd">
    <Graphics>
      <Point GraphRef="da83e"/>
      <Point GraphRef="d916e" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idbe537d08">
    <Graphics>
      <Point GraphRef="bd803"/>
      <Point GraphRef="d916e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id427fa156">
    <Graphics>
      <Point GraphRef="d916e"/>
      <Point GraphRef="d441d" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id4361f83f">
    <Graphics>
      <Point GraphRef="d916e"/>
      <Point GraphRef="e5aca" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8fb3513b">
    <Graphics>
      <Point GraphRef="d441d"/>
      <Point GraphRef="a6b1d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id87a734e1">
    <Graphics>
      <Point GraphRef="d441d"/>
      <Point GraphRef="bdea0" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Label TextLabel="Lipid storage in&#10;white adipocytes" GraphId="e5aca">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Browning mitochondrial&#10;thermogenesis and&#10;beige adipocytes" GraphId="a6b1d">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Group GroupId="c549d" GraphId="d916e" Style="Group"/>
  <Group GroupId="a9c7d" GraphId="d441d" Style="Group"/>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fab">
      <bp:ID >26287746</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >FTO Obesity Variant Circuitry and Adipocyte Browning in Humans.</bp:TITLE>
      <bp:SOURCE >N Engl J Med</bp:SOURCE>
      <bp:YEAR >2015</bp:YEAR>
      <bp:AUTHORS >Claussnitzer M</bp:AUTHORS>
      <bp:AUTHORS >Dankel SN</bp:AUTHORS>
      <bp:AUTHORS >Kim KH</bp:AUTHORS>
      <bp:AUTHORS >Quon G</bp:AUTHORS>
      <bp:AUTHORS >Meuleman W</bp:AUTHORS>
      <bp:AUTHORS >Haugen C</bp:AUTHORS>
      <bp:AUTHORS >Glunk V</bp:AUTHORS>
      <bp:AUTHORS >Sousa IS</bp:AUTHORS>
      <bp:AUTHORS >Beaudry JL</bp:AUTHORS>
      <bp:AUTHORS >Puviindran V</bp:AUTHORS>
      <bp:AUTHORS >Abdennur NA</bp:AUTHORS>
      <bp:AUTHORS >Liu J</bp:AUTHORS>
      <bp:AUTHORS >Svensson PA</bp:AUTHORS>
      <bp:AUTHORS >Hsu YH</bp:AUTHORS>
      <bp:AUTHORS >Drucker DJ</bp:AUTHORS>
      <bp:AUTHORS >Mellgren G</bp:AUTHORS>
      <bp:AUTHORS >Hui CC</bp:AUTHORS>
      <bp:AUTHORS >Hauner H</bp:AUTHORS>
      <bp:AUTHORS >Kellis M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="af6">
      <bp:ID >26287747</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Unraveling the Function of FTO Variants.</bp:TITLE>
      <bp:SOURCE >N Engl J Med</bp:SOURCE>
      <bp:YEAR >2015</bp:YEAR>
      <bp:AUTHORS >Rosen CJ</bp:AUTHORS>
      <bp:AUTHORS >Ingelfinger JR</bp:AUTHORS>
    </bp:PublicationXref>
  <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>obesity disease pathway</bp:TERM><bp:ID>PW:0000540</bp:ID><bp:Ontology>Pathway Ontology</bp:Ontology></bp:openControlledVocabulary><bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>disease pathway</bp:TERM><bp:ID>PW:0000013</bp:ID><bp:Ontology>Pathway Ontology</bp:Ontology></bp:openControlledVocabulary><bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>obesity</bp:TERM><bp:ID>DOID:9970</bp:ID><bp:Ontology>Disease</bp:Ontology></bp:openControlledVocabulary></Biopax>
</Pathway>